Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
ERJ Open Research|December 10, 2024
Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacologyFrancesca A Mercuri, Scott White, Hayley A McQuilten, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2016
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification ConsortiumBruce E Miller, Ruth Tal-Singer, Stephen I Rennard, et al.
The European Respiratory Journal|February 27, 2016
Lung microbiome dynamics in COPD exacerbationsZhang Wang, Mona Bafadhel, Koirobi Haldar, et al.
American Journal of Respiratory and Critical Care Medicine|May 26, 2023
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological TrialsMario Cazzola, Paola Rogliani, Peter J Barnes, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 8, 2017
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populationsJackie C Bloomer, Claire Ambery, Bruce E Miller, et al.
Plos One|October 14, 2015
The Effect of Statins on Blood Gene Expression in COPDMa'en Obeidat, Nick Fishbane, Yunlong Nie, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 25, 2021
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) StudyKentaro Tamaki, Eishin Sakihara, Hiroaki Miyata, et al.
COPD|April 19, 2011
Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPDAnnelyse Duvoix, Elena Miranda, Juan Perez, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2020
The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary diseaseAlison J Dicker, Jeffrey T J Huang, Mike Lonergan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 24, 2022
A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort StudyMasahiro Shinoda, Osamu Hataji, Motohiko Miura, et al.
Pageof 11